Most recent by Sarah O’Brien, MD, MSc
SPONSORED CONTENT
February 10, 2010
3 min read
Save
Is patient compliance a significant barrier to hydroxyurea treatment of children with sickle cell disease?
Many hem/oncs believe that their patients will be not be compliant and do not prescribe the therapy.